S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
Times Cited: 94
Times Cited: 94
Times Cited
Times Co-cited
Similarity
A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
48
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
46
Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
43
Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
41
Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
39
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
36
Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
29
Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
26
Invited essay on the psychological aspects of genetic counseling. V. Preselection: a family coping strategy in Huntington disease.
S Kessler. Am J Med Genet 1988
S Kessler. Am J Med Genet 1988
41
23
Attitudes toward presymptomatic testing in Huntington disease.
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
23
Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
28
Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
21
DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
27
Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
20
A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
20
Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
20
Exploration of the effects of predictive testing for Huntington disease on intimate relationships.
K A Quaid, M K Wesson. Am J Med Genet 1995
K A Quaid, M K Wesson. Am J Med Genet 1995
24
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.
P S Harper, C Lim, D Craufurd. J Med Genet 2000
P S Harper, C Lim, D Craufurd. J Med Genet 2000
19
Testing for Huntington's disease with support for all parties.
A Tibben, M Vegter-vd Vlis, M F vd Niermeijer, J J Kamp, R A Roos, H G Rooijmans, P G Frets, F Verhage. Lancet 1990
A Tibben, M Vegter-vd Vlis, M F vd Niermeijer, J J Kamp, R A Roos, H G Rooijmans, P G Frets, F Verhage. Lancet 1990
42
Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
26
Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
20
On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
18
Presymptomatic testing for huntington diseases: Recommendations for counseling.
K A Quaid. J Genet Couns 1992
K A Quaid. J Genet Couns 1992
51
Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
23
Intended use of predictive testing by those at risk for Huntington disease.
G J Meissen, R L Berchek. Am J Med Genet 1987
G J Meissen, R L Berchek. Am J Med Genet 1987
17
Validity and uses of a screening questionnaire (GHQ) in the community.
A Tarnopolsky, D J Hand, E K McLean, H Roberts, R D Wiggins. Br J Psychiatry 1979
A Tarnopolsky, D J Hand, E K McLean, H Roberts, R D Wiggins. Br J Psychiatry 1979
17
Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
17
Psychological impact of genetic testing for Huntington's disease: an update of the literature.
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
17
The measurement of pessimism: the hopelessness scale.
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
17
A highly polymorphic locus very tightly linked to the Huntington's disease gene.
J J Wasmuth, J Hewitt, B Smith, D Allard, J L Haines, D Skarecky, E Partlow, M R Hayden. Nature 1988
J J Wasmuth, J Hewitt, B Smith, D Allard, J L Haines, D Skarecky, E Partlow, M R Hayden. Nature 1988
17
Developmental tasks of childhood and adolescence: implications for genetic testing.
J H Fanos. Am J Med Genet 1997
J H Fanos. Am J Med Genet 1997
15
Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
20
Age at onset in Huntington's disease: effect of line of inheritance and patient's sex.
R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
18
Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
25
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
15
Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology.
L Went. J Med Genet 1990
L Went. J Med Genet 1990
15
Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
26
Psychological costs and benefits of predictive testing for Huntington's disease.
A M Codori, J Brandt. Am J Med Genet 1994
A M Codori, J Brandt. Am J Med Genet 1994
14
Opinion: predictive testing for Huntington disease in childhood: challenges and implications.
M Bloch, M R Hayden. Am J Hum Genet 1990
M Bloch, M R Hayden. Am J Hum Genet 1990
16
35
At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan.
D S Markel, A B Young, J B Penney. Am J Med Genet 1987
D S Markel, A B Young, J B Penney. Am J Med Genet 1987
14
Paradox of a better test for Huntington's disease.
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
22
Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
14
Improved predictive testing for Huntington disease by using three linked DNA markers.
M R Hayden, C Robbins, D Allard, J Haines, S Fox, J Wasmuth, M Fahy, M Bloch. Am J Hum Genet 1988
M R Hayden, C Robbins, D Allard, J Haines, S Fox, J Wasmuth, M Fahy, M Bloch. Am J Hum Genet 1988
28
Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk.
L A Farrer. Am J Med Genet 1986
L A Farrer. Am J Med Genet 1986
13
A diagnostic interview: the schedule for affective disorders and schizophrenia.
J Endicott, R L Spitzer. Arch Gen Psychiatry 1978
J Endicott, R L Spitzer. Arch Gen Psychiatry 1978
13
Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
20
Partners of Huntington patients: implications of the disease and opinions about predictive testing and prenatal diagnosis.
G Evers-Kiebooms, A Swerts, H Van Den Berghe. Genet Couns 1990
G Evers-Kiebooms, A Swerts, H Van Den Berghe. Genet Couns 1990
52
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.